Top Markets
Coin of the day
Kinnate Biopharma Inc. Kinnate Biopharma Inc.

Kinnate Biopharma Inc.

KNTE
Kedudukan dalam Saham #21072
Kinnate Biopharma Inc. is a U.S.-based biopharmaceutical company primarily... Kinnate Biopharma Inc. is a U.S.-based biopharmaceutical company primarily focused on identifying and advancing small-molecule drugs that target kinase enzymes to treat cancers defined by specific genetic markers. The company's product pipeline includes: KIN-2787: An inhibitor of rapidly accelerated fibrosarcoma (RAF), currently being developed to treat patients with lung cancer, melanoma, and other forms of solid tumors. KIN-3248: A small-molecule kinase inhibitor designed to counteract cancer-associated genetic mutations in the fibroblast growth factor receptors, specifically FGFR2 and FGFR3. KIN004 Program: This program encompasses early-stage small-molecule research, including a Cyclin-Dependent Kinase 12 (CDK12) inhibitor. Established in 2018, Kinnate Biopharma Inc. maintains its headquarters in San Francisco, California. It was formerly a division of Fount Therapeutics, LLC.
Harga Saham
$2.65
Disegerakkan terakhir: 2024-04-03
Modal Pasaran
$115.71M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Kinnate Biopharma Inc. (KNTE)

Kategori

Sejarah harga saham bagi Kinnate Biopharma Inc. (KNTE)
Harga penutupan tertinggi: $2.65 pada 2024-04-01

Harga penutupan terendah: $40.13 pada 2020-12-01
Sejarah harga saham Kinnate Biopharma Inc. dari 2020 hingga 2026
Prestasi harga saham tahunan
Tahun Prestasi
2024 15.54%
2023 -63.61%
2022 -64.96%
2021 -55.12%
2020 0.00%
Harga saham bagi syarikat atau pesaing serupa
Syarikat Harga saham Perubahan 1thn% Negara
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$118.70 -15.60%
AU
$770.19 8.98%
CH